Close this search box.
Covira Surgical (Biotech) on StartEngine
Health & WellnessTech

Covira Surgical (Biotech)

Post-Surgical Infection Prevention
North Chicago, 
Investment type:
Target raise:
 - $1,070,000
Minimum investment:​
End date:
Apr 27, 2022
Our Story

Covira is an early-stage biotech company, a spinout from The University of Chicago, focusing on the prevention of post-surgical infections. Covira’s approach to solving post-operative infections can be transformative to the field and even Business Worldwide Magazine named Covira Surgical Among the 2021- Top 20 Most Innovative Companies to Watch. This microbiome-focused company is based on the work of Dr. John Alverdy, MD, a professor of surgery, practicing gastrointestinal surgeon and world authority on the prevention of post-surgical infections. Covira has developed a proprietary solution phosphate (Pi) conjugated polyethylene glycol (PEG) polymer to reduce infection risk and related complications following surgical procedures.